Bipartisan congressional opposition and explicit administration signals have anchored trader expectations against a Trump pardon or commutation for Ghislaine Maxwell by the end of 2026. In July 2026 the Senate unanimously adopted a non-binding resolution urging no clemency for the convicted sex trafficker, while Acting Attorney General Todd Blanche testified that the Justice Department would not recommend one. House Oversight Chair James Comer has publicly discouraged the move, and White House statements have described it as something the president is not considering. Maxwell’s appeals have been exhausted, leaving executive clemency as her primary remaining option, yet her legal team has noted the ongoing Epstein-files controversy makes immediate pursuit politically costly. Trump has repeatedly stated he has given the matter little thought, has not been formally approached, and would consult the DOJ if needed, without ruling it out. These factors, combined with survivor advocacy and reputational risks tied to her 2021 conviction, sustain the market’s strong consensus.